Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bettina M Prinz Vavricka

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The American Journal of Dermatopathology|August 5, 2009
Diffuse dermal angiomatosis associated with calciphylaxisBettina M Prinz Vavricka, Catherine Barry, Thomas Victor, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2010
Diagnosis of melanoma under concomitant natalizumab therapyBettina M Prinz Vavricka, Peter Baumberger, Stefan Russmann, et al.
Archives of Dermatology|November 23, 2011
Low-dose excimer 308-nm laser for treatment of lichen planopilarisAlexander A Navarini, Antonios G A Kolios, Bettina M Prinz-Vavricka, et al.
International Archives of Allergy and Immunology|September 1, 2006
A cutaneous allergen neutralisation test that correlates with the duration of venom immunotherapyGabriela Senti, Pål Johansen, Ruben Oliver, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2006
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adultsThomas M Kündig, Gabriela Senti, Gabriel Schnetzler, et al.
World Journal of Gastroenterology|June 11, 2014
Late biliary complications in human alveolar echinococcosis are associated with high mortalityPascal Frei, Benjamin Misselwitz, Meher K Prakash, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2008
Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trialGabriela Senti, Bettina M Prinz Vavricka, Iris Erdmann, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The American Journal of Dermatopathology|August 5, 2009
Diffuse dermal angiomatosis associated with calciphylaxisBettina M Prinz Vavricka, Catherine Barry, Thomas Victor, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2010
Diagnosis of melanoma under concomitant natalizumab therapyBettina M Prinz Vavricka, Peter Baumberger, Stefan Russmann, et al.
Archives of Dermatology|November 23, 2011
Low-dose excimer 308-nm laser for treatment of lichen planopilarisAlexander A Navarini, Antonios G A Kolios, Bettina M Prinz-Vavricka, et al.
International Archives of Allergy and Immunology|September 1, 2006
A cutaneous allergen neutralisation test that correlates with the duration of venom immunotherapyGabriela Senti, Pål Johansen, Ruben Oliver, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2006
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adultsThomas M Kündig, Gabriela Senti, Gabriel Schnetzler, et al.
World Journal of Gastroenterology|June 11, 2014
Late biliary complications in human alveolar echinococcosis are associated with high mortalityPascal Frei, Benjamin Misselwitz, Meher K Prakash, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2008
Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trialGabriela Senti, Bettina M Prinz Vavricka, Iris Erdmann, et al.
Pageof 1